ArticleInternational journal of medical sciences2021

PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis.

Peng Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.